Gerd von Wedemeyer

Dr. Rentschler Holding GmbH & Co. KG operates as a holding company with interests in pharmaceutical research and production. Its services include project management, cell line and process developing, as well as analytics and quality controlling solutions. The company was founded in 1927 and is headquartered in Laupheim, Germany.

Rentschler Beteiligungs GmbH is an investment holding German company. The private company is based in Laupheim, Germany. The CEOs are Nikolaus Friedrich Rentschler, Jürgen Müller. The company was founded in 1998.

QIAGEN GmbH provides products for preanalytical sample preparation and molecular diagnostics solutions. It develops and markets consumable products and automated solutions to molecular diagnostics laboratories, academic researchers, pharmaceutical and biotechnology companies, and applied testing customers for purposes such as forensics, animal or food testing and pharmaceutical process control. The company was founded in 1984 and is headquartered in Hilden, Germany.

Part of Institut für Medizinische Diagnostik MVZ GbR, NORDMED Healthcare GmbH is a German company that operates a general practitioner clinic. The company is based in Berlin, Germany. The company was founded in 1992. The CEO is Staffan Percy Ternström.

Part of Medicover AB, Synevo GmbH is an investment holding German company. The company is based in Berlin, Germany. The CEOs are Benedikt von Braunmühl, Carl Fredrik Ragmark. The company was founded in 2007.

PathoQuest SAS provides diagnostic development services for cancer and infectious diseases. Its services include viral safety testing, adventitious virus detection in cell lines under development and in Master Cell Banks, adventitious virus detection in viral stocks, and identify of the sequences of murine sarcoma virus. The company was founded by Luc Boblet and Marc Eloit on September 14, 2010 and is headquartered in Paris, France.

AMGEN GmbH develops, manufactures, and markets human therapeutics based on cellular biology. It was established to help sell and distribute biotechnical therapies for the treatment of such ailments as chemotherapy side effects, chronic kidney failure, and rheumatoid arthritis. Among the group's products are Epogen & Aranesp for the treatment of anemia in people with chronic kidney disease; Neupogen & Neulasta to help restore white blood cell counts for cancer patients and Enbrel for the treatment of psoriasis and rheumatoid arthritis. The company was founded in 1980 and is headquartered in Munich, Germany.

IMD MVZ Beteiligungs GmbH provides investment services. The private company is based in Berlin, Germany. The German company was founded in 2012. Benedikt von Braunmühl has been the CEO of the company since 2018.

Rentschler Immobilien GmbH & Co. KG provides investment services. The private company is based in Laupheim, Germany. The CEO of the German company is Nikolaus Friedrich Rentschler.

IMD Institut für Medizinische Diagnostik GmbH is a medical laboratory company based in Berlin, Germany. and has subsidiaries in Germany. IMD Institut für Medizinische Diagnostik GmbH operates as medical laboratories. The CEO of the German company is Benedikt von Braunmühl.

Part of IMD Institut für Medizinische Diagnostik GmbH, Labormedicus GmbH provides health care services. The company is based in Rostock, Germany. The CEOs of the German company are Hagen Pommerenke, Kristian Meinck, Benedikt von Braunmühl.

HMNC Holding GmbH provides investment services. The company is based in Munich, Germany. The German company was founded by Florian Holsboer. Benedikt von Braunmühl has been the CEO of the company since 2021.

Hmnc Brain Health GmbH is a precision psychiatry biopharma German company that develops personalized therapies for major depressive disorder and treatment-resistant depression. The company is headquartered in Germany and has a presence in both Europe and the United States. Hmnc Brain Health is backed by a renowned VC, several family offices, and a strategic healthcare investor. The CEO of the private company is Benedikt von Braunmühl.

Schering GmbH & Co. Produktions KG manufactures medicines for treating disorders of the menstrual cycle. The company's product Primolut N contains norethisterone which is a progestogen (a female hormone) used to treat irregular, painful or heavy periods. It is also used in the treatment of endometriosis (presence of tissue from the lining of the womb in places where it is not normally found). Schering GmbH was founded in 1851 and is headquartered in Weimar, Germany.

Part of MEDICE Arzneimittel Pütter GmbH & Co. KG, Rentschler Arzneimittel GmbH is a German company that manufactures over-the-counter drugs. The company is based in Laupheim, Germany. Rentschler Arzneimittel was acquired by MEDICE Arzneimittel Pütter GmbH & Co. KG from Dr. Rentschler Holding GmbH & Co. KG on March 16, 2006.

Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.

August Faller GmbH & Co. KG engages in the manufacture and supply of secondary packaging to the pharmaceutical, medical devices, and chemistry industry. It offers folding cartons, leaflets, labels, and combination products. The company was founded by August Faller in 1882 and is headquartered in Waldkirch, Germany.

Part of Servier SAS, Servier Deutschland GmbH is a German company that focuses on meeting the needs of patients and innovation. The company is based in Munich, Germany. The CEOs are Franck Parisot and Oliver Kirst. The company was founded in 1996.

LeukoCare AG develops protein stabilization and protection solutions. The firm specializes in the development of protein stabilization and protection solutions for biopharmaceuticals, vaccines, medical devices, and diagnostics technologies. Its service areas encompass technology licensing, prototyping and product development, clinical registration, biological and chemical testing, and consulting. The company was founded by Martin Scholz in 2001 and is headquartered in Munich, Germany.

leon-nanodrugs GmbH develops oral and parenteral drugs. The firm's services include nanotechnology in medicine, MJR technology, pipeline, partnering with leon and leon network. The company was founded by Wolfgang Beier and Cornelia Beier in 2011 and is headquartered in Munich, Germany.

Catherex, Inc. provides medical research services. The company was founded by Michael A. Christini and is headquartered in Philadelphia, PA.